Sanofi and Regulus form microRNA alliance

Tuesday 22 June 2010

Sanofi-Aventis SA and Regulus Therapeutics Inc have formed a global alliance to develop and commercialise medicines based on microRNA, a class of small ribonucleic acid molecules that regulate gene expression.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France